Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patientsMiao‐Zhen Qiu, Rui‐Hua Xu, Yixin Zhou et al.|BMC Cancer|2014Cited by 70
Nutrition support can bring survival benefit to high nutrition risk gastric cancer patients who received chemotherapyMiao‐Zhen Qiu, Rui‐Hua Xu, Dongsheng Zhang et al.|Supportive Care in Cancer|2014Cited by 66
Bcl‐2/Bcl‐xl inhibitor APG‐1252‐M1 is a promising therapeutic strategy for gastric carcinomaHanjie Yi, Dajun Yang|Cancer Medicine|2020Cited by 49
Novel BCL-2 Inhibitor Lisaftoclax in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematologic Malignancies: First-in-Human Open-Label TrialSikander Ailawadhi, Yifan Zhai, Zi Chen et al.|Clinical Cancer Research|2023Cited by 38
Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or AsciminibElias Jabbour, H. Kantarjian, Vivian G. Oehler et al.|JAMA Oncology|2024Cited by 26